The following publication discusses the latest research regarding the Non-Invasive Biomarkers of Nonalcoholic Steatohepatitis (NASH). Nature Medicine originally published this article, coauthored by ERG’s Vice President of Clinical Pharmacology Services Clay Dehn, on February 10th, 2022.
STUDIES ARE ENROLLING NOW!
Depression
If you or someone you know is affected by depression, upcoming clinical trials may be an option. Learn more today!